FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

37238711000001102: Dacomitinib monohydrate (substance)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 11-May 2022. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    231441000001116 Dacomitinib monohydrate en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    231451000001118 Dacomitinib monohydrate (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Dacomitinib monohydrate Is a Antineoplastic agent false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Dacomitinib 45mg tablets Has specific active ingredient False Dacomitinib monohydrate Inferred relationship Existential restriction modifier
    Dacomitinib 15mg tablets Has specific active ingredient False Dacomitinib monohydrate Inferred relationship Existential restriction modifier
    Dacomitinib 30mg tablets Has specific active ingredient False Dacomitinib monohydrate Inferred relationship Existential restriction modifier
    Vizimpro 30mg tablets (Pfizer Ltd) Has specific active ingredient False Dacomitinib monohydrate Inferred relationship Existential restriction modifier
    Dacomitinib 15mg tablets 30 tablet Has specific active ingredient False Dacomitinib monohydrate Inferred relationship Existential restriction modifier
    Vizimpro 15mg tablets (Pfizer Ltd) Has specific active ingredient False Dacomitinib monohydrate Inferred relationship Existential restriction modifier
    Dacomitinib 30mg tablets 30 tablet Has specific active ingredient False Dacomitinib monohydrate Inferred relationship Existential restriction modifier
    Vizimpro 45mg tablets (Pfizer Ltd) Has specific active ingredient False Dacomitinib monohydrate Inferred relationship Existential restriction modifier
    Vizimpro 30mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient False Dacomitinib monohydrate Inferred relationship Existential restriction modifier
    Vizimpro 45mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient False Dacomitinib monohydrate Inferred relationship Existential restriction modifier
    Vizimpro 15mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient False Dacomitinib monohydrate Inferred relationship Existential restriction modifier
    Dacomitinib 45mg tablets 30 tablet Has specific active ingredient False Dacomitinib monohydrate Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start